Shoback D M, Chen T H
Endocrine Research Unit, San Francisco VA Medical Center, California 94121.
Endocrinology. 1990 Jul;127(1):141-8. doi: 10.1210/endo-127-1-141.
Activators of protein kinase C, such as phorbol myristate acetate (PMA) and the synthetic diacylglycerol dioctanoylglycerol (diC8), either stimulate or inhibit PTH release depending on the extracellular Ca2+ concentration. By increasing PTH release at high extracellular Ca2+, these agents, in effect, block high Ca2(+)-induced inhibition of secretion. Since raising extracellular Ca2+ increases intracellular free Ca2+ ([Ca2+]i) and inositol trisphosphate (InsP3) formation in parathyroid cells, we assessed the effects of PMA pretreatment on [Ca2+]i and InsP3 to ascertain whether these second messengers might be altered by protein kinase C activation. Preincubation of parathyroid cells with PMA (10(-6) M) significantly lowered the intracellular Ca2+ response to raising extracellular Ca2+ from 0.5-2.0 mM. The peak increase in [Ca2+]i averaged 475 +/- 11 nM in PMA-treated cells compared to 703 +/- 44 nM in control cells. High extracellular Ca2(+)-induced InsP3 accumulation was also reduced after incubating the cells with PMA. To determine whether intracellular Ca2+ stores and/or transmembrane Ca2+ uptake were affected by activating protein kinase C, we examined intracellular Ca2+ responses to the Ca2+ ionophore ionomycin after PMA pretreatment. At 0.5 mM Ca2+, ionomycin (10(-6) M) increased [Ca2+]i to an initial peak of 738 +/- 49 nM followed by a sustained increase to 501 +/- 30 nM in control cells (n = 15). After exposure to PMA (greater than or equal to 20 min), however, peak and sustained increments in [Ca2+]i were significantly lower at 550 +/- 32 and 394 +/- 16 nM, respectively (P less than 0.02, n = 8). In the absence of extracellular Ca2+, basal [Ca2+]i was 197 +/- 5 and peaked at 323 +/- 15 nM with ionomycin (10(-6) M) in PMA-treated cells (n = 16). The latter value was significantly less than the peak increase in [Ca2+]i to 461 +/- 19 nM observed with ionomycin (10(-6) M) in control cells (P less than 0.001, n = 15). With respect to secretion, either of the protein kinase C agonists (i.e. PMA or diC8) or the Ca2+ ionophore ionomycin inhibited PTH release at 0.5 mM Ca2+. To determine whether the concomitant activation of protein kinase C- and Ca2(+)-dependent pathways could additively suppress PTH release, we assessed the effects of ionomycin and either PMA or diC8 on secretion. PTH release at 0.5 mM Ca2+ was reduced in an additive manner by either of these protein kinase C agonists plus ionomycin. At 2 mM Ca2+, protein kinase C agonists stimulated PTH release.(ABSTRACT TRUNCATED AT 400 WORDS)
蛋白激酶C的激活剂,如佛波酯肉豆蔻酸乙酸酯(PMA)和合成二酰基甘油二辛酰甘油(diC8),根据细胞外Ca2+浓度,要么刺激要么抑制甲状旁腺激素(PTH)的释放。通过在高细胞外Ca2+水平时增加PTH释放,这些试剂实际上阻断了高Ca2+诱导的分泌抑制。由于提高细胞外Ca2+会增加甲状旁腺细胞内的游离Ca2+([Ca2+]i)和肌醇三磷酸(InsP3)的形成,我们评估了PMA预处理对[Ca2+]i和InsP3的影响,以确定这些第二信使是否可能因蛋白激酶C的激活而改变。用PMA(10^(-6) M)预孵育甲状旁腺细胞,可显著降低细胞内Ca2+对细胞外Ca2+从0.5 mM升高到2.0 mM的反应。在PMA处理的细胞中,[Ca2+]i的峰值增加平均为475±11 nM,而对照细胞中为703±44 nM。在用PMA孵育细胞后,高细胞外Ca2+诱导的InsP3积累也减少了。为了确定激活蛋白激酶C是否会影响细胞内Ca2+储存和/或跨膜Ca2+摄取,我们检测了PMA预处理后细胞内Ca2+对Ca2+离子载体离子霉素的反应。在0.5 mM Ca2+时,离子霉素(10^(-6) M)使对照细胞(n = 15)中的[Ca2+]i增加到初始峰值738±49 nM,随后持续增加到501±30 nM。然而,在暴露于PMA(≥20分钟)后,[Ca2+]i的峰值和持续增加分别显著降低至550±32 nM和394±16 nM(P < 0.02,n = 8)。在无细胞外Ca2+的情况下,PMA处理的细胞(n = 16)中,基础[Ca2+]i为197±5,用离子霉素(10^(-6) M)处理后峰值达到323±15 nM。后一值显著低于对照细胞中用离子霉素(10^(-6) M)处理时观察到的[Ca2+]i峰值增加至461±19 nM(P < 0.001,n = 15)。关于分泌,蛋白激酶C激动剂(即PMA或diC8)或Ca2+离子载体离子霉素在0.5 mM Ca2+时均抑制PTH释放。为了确定蛋白激酶C依赖性途径和Ca2+依赖性途径的同时激活是否能相加性地抑制PTH释放,我们评估了离子霉素与PMA或diC8对分泌的影响。在0.5 mM Ca2+时,这些蛋白激酶C激动剂中的任何一种与离子霉素相加性地降低了PTH释放。在2 mM Ca2+时,蛋白激酶C激动剂刺激PTH释放。(摘要截短至400字)